Mirae Asset Global Investments
XLRN

Mirae Asset Global Investments’s Acceleron Pharma XLRN Stock Holding History

Mirae Asset Global Investments’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,417
Closed -$244K – 1823
2021
Q3 		$244K Buy
+1,417
New +$185K ﹤0.01% 1654

Mirae Asset Global Investments's XLRN Position: Q4 2021 in Review

Mirae Asset Global Investments sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,417 shares — an estimated $244K sold.

Mirae Asset Global Investments first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $244K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Mirae Asset Global Investments reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Mirae Asset Global Investments sold 1,417 Acceleron Pharma shares in Q4 2021, an estimated $244K.
  • Mirae Asset Global Investments first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
  • Mirae Asset Global Investments's Acceleron Pharma position peaked at $244K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Mirae Asset Global Investments's 13F filing for Q4 2021, filed 8 Feb 2022.